The cost of blood: Multidisciplinary consensus conference for a standard methodology

被引:31
作者
Aledort, LM [1 ]
Broder, M [1 ]
Busch, MP [1 ]
Custer, BS [1 ]
Fergusson, DA [1 ]
Goodnough, LT [1 ]
Hofmann, A [1 ]
Klein, HG [1 ]
Louie, JE [1 ]
Page, PL [1 ]
Sazama, K [1 ]
Shander, A [1 ]
Shulman, IA [1 ]
Spence, RK [1 ]
Sullivan, MT [1 ]
Thurer, RL [1 ]
机构
[1] Soc Advancement Blood Management, Milwaukee, WI USA
关键词
D O I
10.1016/j.tmrv.2004.09.05
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Prior attempts to account for the cost of blood have varied in economic perspective, methodology, and scope and may have underestimated both direct and indirect costs associated with transfusions. To devise a comprehensive and standardized methodology for the United States that will improve upon existing estimates, a panel of experts in blood banking and transfusion medicine was assembled and participated in consensus deliberations using modified Delphi methods. As a first step, a process-flow model that describes all the major steps involved in collecting, processing, and transfusing blood such as donor recruitment and follow-up of transfusion sequelae was constructed. Next, interdependencies were outlined and detailed cost elements within each step were itemized. The relative importance of each element was rated. Personnel, screening for infectious agents, information systems, laboratory evaluations, management of transfusion reactions, and equipment were ranked as the most important factors to capture but, in an effort to be all-inclusive, even minor elements were included. This consensus model is broad-based and should serve societal, provider, and payer perspectives for future cost studies. Recognizing the limitations of process-flow models, the next iteration will use an activity-based approach to more fully account for the cost of blood than present estimates. (C) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:66 / 78
页数:13
相关论文
共 33 条
[1]  
Asadi M J, 1996, J Soc Health Syst, V5, P1
[2]   Production of pathogen-inactivated RBC concentrates using PEN110 chemistry: a Phase I clinical study [J].
AuBuchon, JP ;
Pickard, CA ;
Herschel, LH ;
Roger, JC ;
Tracy, JE ;
Purmal, A ;
Chapman, J ;
Ackerman, S ;
Beach, KJ .
TRANSFUSION, 2002, 42 (02) :146-152
[3]   THE COST-EFFECTIVENESS OF PREOPERATIVE AUTOLOGOUS BLOOD DONATION FOR TOTAL HIP AND KNEE REPLACEMENT [J].
BIRKMEYER, JD ;
GOODNOUGH, LT ;
AUBUCHON, JP ;
NOORDSIJ, PG ;
LITTENBERG, B .
TRANSFUSION, 1993, 33 (07) :544-551
[4]   An evaluation of the process and costs associated with targeted lookbacks for HCV and general notification of transfusion recipients [J].
Callum, JL ;
Pinkerton, PH ;
Coovadia, AS ;
Thomson, AE ;
Dewsbury, F .
TRANSFUSION, 2000, 40 (10) :1169-1175
[5]   Costs of blood transfusion: A process-flow analysis [J].
Cantor, SB ;
Hudson, DV ;
Lichtiger, B ;
Rubenstein, EB .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (07) :2364-2370
[6]   Cost of outpatient blood transfusion in cancer patients [J].
Crémieux, PY ;
Barrett, B ;
Anderson, K ;
Slavin, MB .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (14) :2755-2761
[7]  
CUSTER BS, 2003, THESIS U WASHINGTON
[8]  
DRUMMOND MF, 1987, COST ANAL METHODS EC, P39
[9]   Cost analysis of autologous blood transfusion, using cell salvage, compared with allogeneic blood transfusion [J].
Duffy, G ;
Tolley, K .
TRANSFUSION MEDICINE, 1997, 7 (03) :189-196
[10]   THE COST-EFFECTIVENESS OF PREOPERATIVE AUTOLOGOUS BLOOD DONATIONS [J].
ETCHASON, J ;
PETZ, L ;
KEELER, E ;
CALHOUN, L ;
KLEINMAN, S ;
SNIDER, C ;
FINK, A ;
BROOK, R .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (11) :719-724